A review on 'Biomarkers' as diagnostic tool

International Journal of Pharmaceutical Sciences Review and Research

Volumn 7, Issue 1, 2011, Pages 54-58

  Kinja, Kuldeep ^a   Gupta, N ^a  

^a NIMS UNIVERSITY   (India)

Author keywords

Antecedent biomarkers; Cancer biomarkers; Cardiac biomarkers; Diagnostic biomarkers

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TOXIN; TROPONIN;

ACUTE CORONARY SYNDROME; BIOCHEMISTRY; CLINICAL EXAMINATION; CONFOUNDING VARIABLE; CONSTRUCT VALIDITY; CONTENT VALIDITY; CRITERION RELATED VALIDITY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG RESEARCH; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENETIC SUSCEPTIBILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEASUREMENT ERROR; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PATHOGENESIS; POINT OF CARE TESTING; PREDICTIVE VALUE; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REPRODUCIBILITY; REVIEW; RISK FACTOR; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC ERROR; TREATMENT OUTCOME;

EID: 80052680874     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Hulka BS. Overview of biological markers. Biological markers in epidemiology, New York: Oxford University Press, 1990; 3-15.
2. Naylor S. Biomarkers: current perspectives and future prospects. Expert Rev MolDiagn 2003; 3: 525-529.
3. Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 21: 2000: 517-524.
4. Gordis L. Epidemiology and public policy. Epidemiology. Philadelphia: W.B. Saunders, 1996: 247-256.
5. Verbeek MM, De Jong D, Kremer HP. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann J ClinBiochem 2003; 40: 25-40.
6. Galasko D. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. ClinGeriatr Med 2001; 17: 393-410.
7. Rohlff C. Proteomics in neuropsychiatric disorders. Int. J Neuropsychopharmacol 2001; 4: 93-102.
8. Reiber H, Peter JB. Cerebrospinal fluid analysis: diseaserelated data patterns and evaluation programs. J NeurolSci 2001; 184: 101-122.
9. Schulte PA. A conceptual and historical framework for molecular epidemiology. San Diego: Academic Press, 1993: 3-44.
10. Merikangas K. Genetic epidemiology: bringing genetics to the population-the NAPE Lecture 2001. Acta PsychiatrScand 2002; 105: 3-13.
11. Muller U, Graeber MB. Neurogenetic diseases: molecular diagnosis and therapeutic approaches. J Mol Med 1996; 74: 71-84.
12. Mayeux R. Epidemiology of neuro degeneration. Annu Rev Neurosci 2003; 26: 81-104.
13. Christenson, R., Editor (© 2007). Biomarkers of Acute Coronary Syndrome and Heart Failure. National Academy of Clinical Biochemistry, Laboratory Medicine Practice Guidelines. Available online at http://www.aacc.org/AACC/members/nacb/LMPG/OnlineGuide/PublishedGuidelines/ACSHeart
14. Weinrauch L. (2007 March 30, Updated). Heart Attack. MedlinePlus Medical Encyclopedia. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000195.htm.
15. (2007 May). What is a Heart Attack. National Heart Lung and Blood Institute. Available online at http://www.nhlbi.nih.gov/health/dci/Diseases/HeartAttack/HeartAttack.html.
16. Schreiber, D. and Miller, S. (2006 June 26, Updated). Use of Cardiac Markers in the Emergency Department. emedicine. Available online at http://www.emedicine.com/emerg/TOPIC932.HTM.
17. Clinical Laboratory News: New NACB Guidelines Emphasize Cardiac Troponin for ACS. Clinical Laboratory News April 2007: V33 (4).
18. Kathleen D. & Pagana, Timothy J. Mosby's Diagnostic and Laboratory Test Reference; 8th Edition: Mosby, Inc., Saint Louis, MO.2007; 319, 321, 668-670.
19. Clarke, W. and Dufour, D. R., Editors. Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC.2006; 306-315.
20. Bouras, T., Southey, M. C, and Venter, D. J. Overexpression of the steroid receptor coactivator AIB 1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res,2001; 61: 903-907.
21. Cloven, N. G., Kyshtoobayeva, A., Burger, R. A., Yu, I. R., and Fruehauf, J. P. In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer. GynecolOncol, 2004; 92: 160-166.
22. Schulte, PA, Perera FP. Validation. In: Molecular epidemiology: principles and practices (Schulte PA, Perera FP, eds),. San Diego: Academic Press, 1993: 79-107.
23. Pepe MS, Thompson ML. Combining diagnostic test results to increase accuracy. Biostatistics 2000; 1: 123-140.
24. Thompson ML, Zucchini W. On the statistical analysis of ROC curves. Stat Med 1989; 8:1277-1290